| For: | Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol 2012; 18(29): 3790-3799 [PMID: 22876029 DOI: 10.3748/wjg.v18.i29.3790] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i29/3790.htm |
| Number | Citing Articles |
| 1 |
Eyal Klang, Shelly Soffer, Eyal Shachar, Adi Lahat. Trends in inflammatory bowel disease infections and vaccinations in the past four decades: A high-level text mining analysis of PubMed publications. Human Vaccines & Immunotherapeutics 2022; 18(5) doi: 10.1080/21645515.2022.2065814
|
| 2 |
Antony Aziz, Rebecca Reynolds, Azhar Ansari. Process and Systems: A population-based model of care for people with inflammatory bowel disease – patient-reported outcomes. Future Healthcare Journal 2019; 6(1) doi: 10.7861/futurehosp.6-1-30
|
| 3 |
|
| 4 |
Hui-Jing Zhang, Yi-Ning Zhang, Huan Zhou, Lin Guan, Yue Li, Ming-Jun Sun. IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT. Digestive Diseases and Sciences 2018; 63(11) doi: 10.1007/s10620-018-5234-x
|
| 5 |
Noam Jacob, Stephan R Targan, David Q Shih. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterology Journal 2016; 4(4) doi: 10.1177/2050640616649356
|
| 6 |
Mônica O. Belém, Giovana M.M. de Andrade, Thalita M. Carlos, Carla F.S. Guazelli, Victor Fattori, Dari O. Toginho Filho, Ivan F.L. Dias, Waldiceu A. Verri, Eduardo J.A. Araújo. Light-emitting diodes at 940 nm attenuate colitis-induced inflammatory process in mice. Journal of Photochemistry and Photobiology B: Biology 2016; 162 doi: 10.1016/j.jphotobiol.2016.07.008
|
| 7 |
Yunhai Li, Ping Chen, Jiazheng Sun, Jing Huang, Hongtao Tie, Liangliang Li, Hongzhong Li, Guosheng Ren. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep33550
|
| 8 |
Noam Jacob, Jonathan P. Jacobs, Kotaro Kumagai, Connie W.Y. Ha, Yoshitake Kanazawa, Venu Lagishetty, Katherine Altmayer, Ariel M. Hamill, Aimee Von Arx, R. Balfour Sartor, Suzanne Devkota, Jonathan Braun, Kathrin S. Michelsen, Stephan R. Targan, David Q. Shih. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Mucosal Immunology 2018; 11(5) doi: 10.1038/s41385-018-0055-y
|
| 9 |
Palle Bager, Susanna Jäghult. Adherence in inflammatory bowel disease (IBD): a clinical review. Gastrointestinal Nursing 2019; 17(6) doi: 10.12968/gasn.2019.17.6.24
|
| 10 |
Lars F. Hansen, Christian Jakobsen, Anders Paerregaard, Niels Qvist, Vibeke Wewer. Surgery and Postoperative Recurrence in Children With Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(3) doi: 10.1097/MPG.0000000000000616
|
| 11 |
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 2016; 10(8) doi: 10.1093/ecco-jcc/jjw055
|
| 12 |
Rajmohan Dharmaraj, Melodee Nugent, Pippa Simpson, Marjorie Arca, Bhaskar Gurram, Steven Werlin. Outcomes after fecal diversion for colonic and perianal Crohn disease in children. Journal of Pediatric Surgery 2018; 53(3) doi: 10.1016/j.jpedsurg.2017.08.011
|
| 13 |
Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, Eleonora Patsenker, Felix Stickel, Sebastian Mueller, Senta Hutter, Cordelia Schuler, Katharina Baebler, Yu Wang, Céline Mamie, Gerard Dijkstra, Cheryl de Vallière, Pedro H Imenez Silva, Carsten A Wagner, Isabelle Frey-Wagner, Pedro A Ruiz, Klaus Seuwen, Gerhard Rogler, Martin Hausmann. New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4. Inflammatory Bowel Diseases 2022; 28(1) doi: 10.1093/ibd/izab140
|
| 14 |
Christine Sturm, Anika E. Wagner. Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways. International Journal of Molecular Sciences 2017; 18(9) doi: 10.3390/ijms18091890
|
| 15 |
Rachel L Randell, Ajay S Gulati, Suzanne F Cook, Christopher F Martin, Wenli Chen, Elizabeth L Jaeger, Alexi A Schoenborn, Patricia V Basta, Hendrik Dejong, Jingchun Luo, Marisa Gallant, Robert S Sandler, Millie D Long, Michael D Kappelman. Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study. JMIR Research Protocols 2016; 5(1) doi: 10.2196/resprot.5171
|
| 16 |
Gianluca Pellino, Pierlorenzo Pallante, Francesco Selvaggi. Novel biomarkers of fibrosis in Crohn’s disease. World Journal of Gastrointestinal Pathophysiology 2016; 7(3): 266-275 doi: 10.4291/wjgp.v7.i3.266
|
| 17 |
Wee Khoon Ng, Siew C. Ng. Fibrostenotic Inflammatory Bowel Disease. 2018; doi: 10.1007/978-3-319-90578-5_2
|
| 18 |
Ersilia M. DeFilippis, Randy Longman, Michael Harbus, Kyle Dannenberg, Ellen J. Scherl. Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Current Gastroenterology Reports 2016; 18(3) doi: 10.1007/s11894-016-0487-z
|
| 19 |
|
| 20 |
Bobby Lo, Mette Julsgaard, Marianne Kajbæk Vester-Andersen, Ida Vind, Johan Burisch. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study. European Journal of Gastroenterology & Hepatology 2018; 30(10) doi: 10.1097/MEG.0000000000001199
|
| 21 |
Wenhong Wang, Ke Li, Dandan Bai, Jiabin Wu, Weihua Xiao. Pterostilbene: a potential therapeutic agent for fibrotic diseases. Inflammopharmacology 2024; 32(2) doi: 10.1007/s10787-024-01440-z
|
| 22 |
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancer. Journal of Coloproctology 2017; 37(01) doi: 10.1016/j.jcol.2016.06.005
|
| 23 |
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysis. Inflammation 2014; 37(3) doi: 10.1007/s10753-013-9798-5
|
| 24 |
Chase Cockrell, Scott Christley, Gary An, Feilim Mac Gabhann. Investigation of Inflammation and Tissue Patterning in the Gut Using a Spatially Explicit General-Purpose Model of Enteric Tissue (SEGMEnT). PLoS Computational Biology 2014; 10(3) doi: 10.1371/journal.pcbi.1003507
|
| 25 |
Annibale D’Annibale, Maria C. Di Paolo, Graziano Pernazza, Vito Pende, Giorgio Lucandri, Paolo Mazzocchi, Giovanni Alfano. Atlas of Ileoscopy. 2013; doi: 10.1007/978-88-470-5205-5_27
|
| 26 |
Hao Chen, Mee Yong Bartee, Jordan R. Yaron, Liying Liu, Liqiang Zhang, Donghang Zheng, Ian B. Hogue, Whitney L. Bullard, Scott Tibbetts, Alexandra R. Lucas. Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR−/−) That Is Blocked by Interleukin-10. Viruses 2018; 10(10) doi: 10.3390/v10100518
|
| 27 |
Yang Yang, Qi-Shan Zeng, Min Zou, Jian Zeng, Jiao Nie, DongFeng Chen, Hua-Tian Gan. Targeting Gremlin 1 Prevents Intestinal Fibrosis Progression by Inhibiting the Fatty Acid Oxidation of Fibroblast Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.663774
|
| 28 |
Stephanie C. Montgomery, Cayla M. Williams, Pinkney J. Maxwell. Nutritional Support of Patient with Inflammatory Bowel Disease. Surgical Clinics of North America 2015; 95(6) doi: 10.1016/j.suc.2015.08.006
|
| 29 |
Murtaza M. Tambuwala. Natural Nuclear Factor Kappa Beta Inhibitors. Inflammatory Bowel Diseases 2016; 22(3) doi: 10.1097/MIB.0000000000000655
|
| 30 |
C. C. Dias, P. P. Rodrigues, A. d. Costa-Pereira, F. Magro. Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies. Journal of Crohn's and Colitis 2015; 9(2) doi: 10.1093/ecco-jcc/jju016
|
| 31 |
Amit Arya, Dharam Pal Pathak, Dipak K. Majumdar, Satish Manchanda. Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulations. Designed Monomers and Polymers 2016; 19(1) doi: 10.1080/15685551.2015.1092011
|
| 32 |
Taha Rashid, Alan Ebringer, Clyde Wilson. The Role ofKlebsiellain Crohn’s Disease with a Potential for the Use of Antimicrobial Measures. International Journal of Rheumatology 2013; 2013 doi: 10.1155/2013/610393
|
| 33 |
Juan Li, Wei Zhong, Weiwei Wang, Shaoping Hu, Jiahui Yuan, Bing Zhang, Tianhui Hu, Gang Song, Lucienne Chatenoud. Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation. PLoS ONE 2014; 9(2) doi: 10.1371/journal.pone.0087810
|
| 34 |
Aswini Pujahari. Unusual Cause of Colonic Obstruction: A Case Report. Gastroenterology & Hepatology: Open Access 2016; 4(1) doi: 10.15406/ghoa.2016.04.00088
|
| 35 |
Weitao Hu, Taiyong Fang, Mingxuan Zhou, Xiaoqing Chen. Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33292-y
|
| 36 |
Alberto Caruso, Giovanni Latella, Dina Di Giacomo, Marco Cavicchioli, Federica Galli. Inflammatory bowel diseases (IBDs): a cross-sectional analysis of the psychological and biological mechanisms underlying intestinal and extra-intestinal symptoms—GastroPsy study protocol. BMJ Open 2025; 15(11) doi: 10.1136/bmjopen-2025-103374
|
| 37 |
Eoin P Cummins, Glen A Doherty, Cormac T Taylor. Hydroxylases as therapeutic targets in inflammatory bowel disease. Laboratory Investigation 2013; 93(4) doi: 10.1038/labinvest.2013.9
|
| 38 |
Fedor V. Vityazev, Maiia I. Fedyuneva, Victoria V. Golovchenko, Olga A. Patova, Elena U. Ipatova, Eugene A. Durnev, Ekaterina A. Martinson, Sergey G. Litvinets. Pectin-silica gels as matrices for controlled drug release in gastrointestinal tract. Carbohydrate Polymers 2017; 157 doi: 10.1016/j.carbpol.2016.09.048
|
| 39 |
Tuula Peñate Medina, Jan Philip Kolb, Gereon Hüttmann, Robert Huber, Oula Peñate Medina, Linh Ha, Patricia Ulloa, Naomi Larsen, Arianna Ferrari, Magdalena Rafecas, Mark Ellrichmann, Mariya S. Pravdivtseva, Mariia Anikeeva, Jana Humbert, Marcus Both, Jennifer E. Hundt, Jan-Bernd Hövener. Imaging Inflammation – From Whole Body Imaging to Cellular Resolution. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.692222
|
| 40 |
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-Analysis. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0109625
|
| 41 |
Duy Vu Le, Renuka Gupte, Meghan Hufstader Gabriel, Varun Vaidya. Inflammatory bowel disease: cost-driving factors and impact of cost sharing on outpatient resource utilization. Journal of Pharmaceutical Health Services Research 2018; 9(4) doi: 10.1111/jphs.12244
|
| 42 |
Dina Chokr, Marjorie Cornu, Christel Neut, Clovis Bortolus, Rogatien Charlet, Pierre Desreumaux, Silvia Speca, Boualem Sendid. Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00401-z
|
| 43 |
Shelley B. Weisser, Lisa K. Kozicky, Hayley K. Brugger, Eyler N. Ngoh, Bonnie Cheung, Roger Jen, Susan C. Menzies, Asanga Samarakoon, Peter J. Murray, C. James Lim, Pauline Johnson, Jean‐Luc Boucher, Nico van Rooijen, Laura M. Sly. Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation. European Journal of Immunology 2014; 44(11) doi: 10.1002/eji.201343981
|
| 44 |
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(6) doi: 10.3390/ijms140611392
|
| 45 |
Prema Robinson, Emily Magness, Kelsey Montoya, Nikita Engineer, Thomas Eckols, Emma Rodriguez, David Tweardy. Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease. Journal of Clinical Medicine 2022; 11(23) doi: 10.3390/jcm11237020
|
| 46 |
Mariam Mohamed Abdou, Lucas Kreiß, Benjamin Schmid, Oana-Maria Thoma, René Krüger, Alan Bénard, Tanja M. Müller, Annkathrin Knauss, Michael Gabel, Miguel González-Acera, Yanmin Lyu, Katja Petter, Aylin Lindemann, Mina Saad Aziz Saad, Philip Eichhorn, Christoph Becker, Elisabeth Naschberger, Sebastian Zundler, Benno Weigmann, Timo Rath, Raja Atreya, Anja A. Kühl, Zlatko Trajanoski, Imke Atreya, Petra Bacher, Christian Bojarski, Caroline Bosch-Voskens, Hyun-Dong Chang, Andreas Diefenbach, Claudia Günther, Ahmed N. Hegazy, Kai Hildner, Christoph S.N. Klose, Kristina Koop, Susanne Krug, Moritz Leppkes, Rocío López-Posadas, Leif S.-H. Ludwig, Clemens Neufert, Jay V. Patankar, Christina Plattner, Magdalena Prüß, Andreas Radbruch, Chiara Romagnani, Francesca Ronchi, Ashley Sanders, Alexander Scheffold, Jörg-Dieter Schulzke, Michael Schumann, Britta Siegmund, Antigoni Triantafyllopoulou, Carl Weidinger, Stefan Wirtz, Oliver Friedrich, Maximilian J. Waldner, Markus F. Neurath, Martin Herrmann, Sebastian Schürmann, Nathalie Britzen-Laurent, Michael Stürzl. Early Gut–Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models. Cellular and Molecular Gastroenterology and Hepatology 2026; doi: 10.1016/j.jcmgh.2026.101795
|
| 47 |
Devendra Desai. Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access 2015; 3(2) doi: 10.15406/ghoa.2015.03.00076
|
| 48 |
Cecelia Kelly, R. Balfour Sartor, John F. Rawls. Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies. American Journal of Physiology-Gastrointestinal and Liver Physiology 2025; 328(1) doi: 10.1152/ajpgi.00252.2024
|
| 49 |
Ian C. Lawrance, Gerhard Rogler, Giorgos Bamias, Christine Breynaert, Jon Florholmen, Gianluca Pellino, Shimon Reif, Silvia Speca, Giovanni Latella. Cellular and Molecular Mediators of Intestinal Fibrosis. Journal of Crohn's and Colitis 2015; doi: 10.1016/j.crohns.2014.09.008
|
| 50 |
Chase Cockrell, Gary An. Complex Systems and Computational Biology Approaches to Acute Inflammation. 2021; doi: 10.1007/978-3-030-56510-7_13
|
| 51 |
Yanni Fan, Ling Zhang, Negar Omidakhsh, Rhonda L. Bohn, Kathleen Putnam, A. Shola Adewale, Gil Y. Melmed. Progression of Crohn’s Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data. Digestive Diseases and Sciences 2024; 69(11) doi: 10.1007/s10620-024-08591-7
|
| 52 |
Nancy Gupta, Sam Papasotiriou, Stephen Hanauer. The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology 2023; 19(9) doi: 10.1080/1744666X.2023.2214728
|
| 53 |
Guohui Xue, Lin Hua, Nanjin Zhou, Junming Li. Characteristics of immune cell infiltration and associated diagnostic biomarkers in ulcerative colitis: results from bioinformatics analysis. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2020.1863016
|
| 54 |
Noam Jacob, Kotaro Kumagai, Jay P. Abraham, Yosuke Shimodaira, Yuefang Ye, Justin Luu, Anna Y. Blackwood, Sofi L. Castanon, Dalton T. Stamps, Lisa S. Thomas, Rivkah Gonsky, David Q. Shih, Kathrin S. Michelsen, Stephan R. Targan. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75168-5
|
| 55 |
Paulo José Basso, Helioswilton Sales-Campos, Viviani Nardini, Murillo Duarte-Silva, Vanessa Beatriz Freitas Alves, Giuliano Bonfá, Cassiano Costa Rodrigues, Bruno Ghirotto, Javier Emílio Lazo Chica, Auro Nomizo, Cristina Ribeiro de Barros Cardoso. Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.618365
|
| 56 |
Gareth P. Gilna, Rebecca A. Saberi, Christopher F. O'Neil, Walter A. Ramsey, Carlos T. Huerta, Amber H. Langshaw, Joshua P. Parreco, Juan E. Sola, Chad M. Thorson, Eduardo A. Perez. Disparities in utilization of laparoscopic colectomies in pediatric Crohn's disease✰. Journal of Pediatric Surgery 2022; 57(6) doi: 10.1016/j.jpedsurg.2022.01.030
|
| 57 |
Fangli Yang, Danan Wang, Yan Li, Lixuan Sang, Junfeng Zhu, Jinyan Wang, Bing Wei, Changlong Lu, Xun Sun. Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced Colitis. Journal of Immunology Research 2017; 2017 doi: 10.1155/2017/7047201
|
| 58 |
Filippo Vernia, Marco Valvano, Stefano Fabiani, Gianpiero Stefanelli, Salvatore Longo, Angelo Viscido, Giovanni Latella. Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review. Cancers 2021; 13(10) doi: 10.3390/cancers13102361
|
| 59 |
Adi Lahat, Ido Veisman. Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool. Diagnostics 2021; 11(10) doi: 10.3390/diagnostics11101737
|
| 60 |
Anna Viola, Maria Giulia Demarzo, Alfredo Abbruzzese, Marco Muscianisi, Michele Francesco Chiappetta, Giuseppe Costantino, Omar Ksissa, Angela Alibrandi, Walter Fries. Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center. Patient Preference and Adherence 2023; doi: 10.2147/PPA.S390349
|
| 61 |
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The ‐A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysis. Journal of Digestive Diseases 2015; 16(4) doi: 10.1111/1751-2980.12232
|
| 62 |
Yava L. Jones-Hall, Cindy H. Nakatsu. The Intersection of TNF, IBD and the Microbiome. Gut Microbes 2016; 7(1) doi: 10.1080/19490976.2015.1121364
|
| 63 |
Trevor van Mierlo, Rachel Fournier, Richard Fedorak. Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR mHealth and uHealth 2015; 3(1) doi: 10.2196/mhealth.3987
|
| 64 |
Eyal Klang, Yiftach Barash, Shelly Soffer, Eyal Shachar, Adi Lahat. Trends in inflammatory bowel disease treatment in the past two decades‐a high‐level text mining analysis of PubMed publications. United European Gastroenterology Journal 2021; 9(9) doi: 10.1002/ueg2.12138
|
| 65 |
Gilberto Poggioli, Nicola Renzi. Ulcerative Colitis. Updates in Surgery 2019; doi: 10.1007/978-88-470-3977-3_2
|
| 66 |
Gulustan H. Babayeva, Hikmet I. Ibrahimli, Sergiy V. Holub, Umud R. Mahmudov, Ferid V. Guliyev, Jamal S. Musayev, Emin Kh. Verdiyev, Gunay V. Asadova, Rashad A. Hasanov, Habil M. Huseynov, Aychin I. Hasanova, Tunzala A. Maharramova. Miscellaneous Considerations in Inflammatory Bowel Disease. 2024; doi: 10.5772/intechopen.1003935
|
| 67 |
Hui-Jun Tang, Cai-Qun Bie, Li-Liangzi Guo, Li-Xian Zhong, Shao-Hui Tang. Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine 2023; 25(6) doi: 10.3892/etm.2023.11997
|
| 68 |
Christine Olbjørn, Britt Nakstad, Milada C. Småstuen, Espen Thiis-Evensen, Morten H. Vatn, Gøri Perminow. Early anti-TNF treatment in pediatric Crohn’s disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients. Scandinavian Journal of Gastroenterology 2014; 49(12) doi: 10.3109/00365521.2014.966316
|
| 69 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Preliminary Study for a Bayesian Network Prognostic Model for Crohn's Disease. 2015 IEEE 28th International Symposium on Computer-Based Medical Systems 2015; doi: 10.1109/CBMS.2015.40
|
| 70 |
Min Dai, Ting Zhang, Qianqian Li, Bota Cui, Liyuan Xiang, Xiao Ding, Rong Rong, Jianling Bai, Jianguo Zhu, Faming Zhang. The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-018-3101-x
|
| 71 |
Tianzhen He, Kai Wang, Peng Zhao, Guanqun Zhu, Xinbao Yin, Yulian Zhang, Zongliang Zhang, Kai Zhao, Zhenlin Wang, Ke Wang. Integrative computational approach identifies immune‐relevant biomarkers in ulcerative colitis. FEBS Open Bio 2022; 12(2) doi: 10.1002/2211-5463.13357
|
| 72 |
Martin Hausmann, Klaus Seuwen, Cheryl de Vallière, Moana Busch, Pedro A. Ruiz, Gerhard Rogler. Role of pH-sensing receptors in colitis. Pflügers Archiv - European Journal of Physiology 2024; 476(4) doi: 10.1007/s00424-024-02943-y
|
| 73 |
Talat Bessissow, Gert Van Assche. Fibrostenotic Inflammatory Bowel Disease. 2018; doi: 10.1007/978-3-319-90578-5_16
|
| 74 |
Ariel Israel, Kassem Sharif, Galit Zada, Amir Friedenberg, Shlomo Vinker, Adi Lahat. Comparative Analysis of Inflammatory Bowel Disease Management. Journal of Clinical Gastroenterology 2025; 59(8) doi: 10.1097/MCG.0000000000002088
|
| 75 |
Mohamed Hassanein, Li Xi, Rathi D. Ryan, Zhan (Harold) Ye, Nessy Tania, Yamato Sano, Joshua Varghese, Diogo Branquinho, Anna Sapone. Advancing IBD Management: A Literature Review on the Role of Non‐Invasive Blood‐Based Biomarkers in Predicting and Assessing Pharmacodynamic Response to Treatment. Clinical and Translational Science 2026; 19(5) doi: 10.1111/cts.70562
|
| 76 |
Noam Jacob, Stephan R. Targan, David Q. Shih. Fibrostenotic Inflammatory Bowel Disease. 2018; doi: 10.1007/978-3-319-90578-5_5
|
| 77 |
Kazuo Kitamura, Shinya Ashizuka, Haruhiko Inatsu, Toshihiro Kita. Innovative Medicine. 2015; doi: 10.1007/978-4-431-55651-0_19
|
| 78 |
Cheryl de Vallière, Jesus Cosin-Roger, Katharina Baebler, Anja Schoepflin, Céline Mamie, Michelle Mollet, Cordelia Schuler, Susan Bengs, Silvia Lang, Michael Scharl, Klaus Seuwen, Pedro A. Ruiz, Martin Hausmann, Gerhard Rogler. pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031419
|
| 79 |
Adi Lahat, Uri Kopylov, Sandra Neuman, Nina Levhar, Doron Yablecovitch, Benjamin Avidan, Batia Weiss, Shomron Ben-Horin, Rami Eliakim. Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0588-7
|
| 80 |
Giovanni Latella, Jacopo Di Gregorio, Vincenzo Flati, Florian Rieder, Ian C. Lawrance. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scandinavian Journal of Gastroenterology 2015; 50(1) doi: 10.3109/00365521.2014.968863
|
| 81 |
Fatma S. Samman, Samah M. Elaidy, Soha S. Essawy, Mohammad S. Hassan. New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in rats. Pharmacological Reports 2018; 70(3) doi: 10.1016/j.pharep.2017.11.015
|
| 82 |
Amandeep Singh, Neha Agrawal, Satya Kurada, Rocio Lopez, Hermann Kessler, Jessica Philpott, Bo Shen, Bret Lashner, Florian Rieder. Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn’s Disease-associated Strictures—A Cohort Study. Journal of Crohn's and Colitis 2017; 11(9) doi: 10.1093/ecco-jcc/jjx078
|
| 83 |
Deepak Selvakumar, Jamie Hall, Olivia Hawksworth, Daniel Hind, Stephen Walters, Ines Rombach, Esther Herbert, William Waterworth, Lucy Sibbald, Mark Travis, Daniel Brice, Alan Lobo, Laura Hancock, Steven Brown. Mesenteric excision and Kono‐S anastomosis trial (MEErKAT): A study protocol for a multicentre, 2 × 2 factorial, randomised controlled, open‐label superiority trial. Colorectal Disease 2025; 27(9) doi: 10.1111/codi.70212
|
| 84 |
Lígia N.M. Ribeiro, Ana C.S. Alcântara, Margarita Darder, Pilar Aranda, Fernando M. Araújo-Moreira, Eduardo Ruiz-Hitzky. Pectin-coated chitosan–LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. International Journal of Pharmaceutics 2014; 463(1) doi: 10.1016/j.ijpharm.2013.12.035
|
| 85 |
Sun-Mi Yun, Seok-Ho Kim, Eun-Hee Kim. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00162
|
| 86 |
Usman T. Siddiqui, Hira Shahzad, Asad Jamil Raja. Pneumoperitoneum, pneumoretroperitoneum, pneumomediastinum and extensive subcutaneous emphysema in a patient with ulcerative colitis. International Journal of Surgery Case Reports 2015; 17(C) doi: 10.1016/j.ijscr.2015.09.038
|
| 87 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Disabling and Reoperation in Patients with Crohn's Disease Subject to Early Surgery or Immunosuppression: A Bayesian Network Prognostic Model. 2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS) 2016; doi: 10.1109/CBMS.2016.65
|
| 88 |
Ioannis Koutsounas, Emmanouil Pyleris, Panagiotis Karantanos, Charalambos Barbatzas. First Diagnosis of Inflammatory Bowel Disease in a 91-Year-Old Man. Case Reports in Gastroenterology 2012; 6(3) doi: 10.1159/000346467
|
| 89 |
Khalid A. Abdelhalim, Ataç Uzel, Nalan Gülşen Ünal. Virulence determinants and genetic diversity of adherent-invasive Escherichia coli (AIEC) strains isolated from patients with Crohn's disease. Microbial Pathogenesis 2020; 145 doi: 10.1016/j.micpath.2020.104233
|
| 90 |
Mais Khasawneh, Andrew D. Spence, Jennifer Addley, Patrick B. Allen. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2017; 31(5) doi: 10.1016/j.bpg.2017.10.004
|
| 91 |
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2017; 29(8) doi: 10.1097/MEG.0000000000000877
|